DAX-1 inhibits hepatocellular carcinoma proliferation by inhibiting β-catenin transcriptional activity

Cellular Physiology and Biochemistry

Volumn 34, Issue 3, 2014, Pages 734-742

  Jiang, Hong Lei ^a   Xu, Dong ^a   Yu, Hao ^a   Ma, Xu ^a   Lin, Guo Fu ^a   Ma, Dong Yan ^a   Jin, Jun Zhe ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Cell proliferation; DAX1; Hepatocellular carcinoma; Catenin

Indexed keywords

BETA CATENIN; BROXURIDINE; MESSENGER RNA; NUCLEAR RECEPTOR DAX 1; SMALL INTERFERING RNA; NR0B1 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER CELL LINE; CANCER TISSUE; CELL CYCLE ASSAY; CELL INVASION ASSAY; CELL MIGRATION ASSAY; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; LIVER CELL CARCINOMA; MALE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; WESTERN BLOTTING; GENETIC TRANSCRIPTION; GENETICS; LIVER TUMOR; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; TUMOR INVASION;

BETA CATENIN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; DAX-1 ORPHAN NUCLEAR RECEPTOR; DOWN-REGULATION; HUMANS; LIVER NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; TRANSCRIPTION, GENETIC;

EID: 84906591389     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000363038     Document Type: Article

References (21)

1. Song P, Gao J, Inagaki Y, Kokudo N, Hasegawa K, Sugawara Y, Tang W: Biomarkers: Evaluation of screening for and early diagnosis of hepatocellular carcinoma in japan and china. Liver cancer 2013;2:31-39.
2. Li Y, Tang ZY, Hou JX: Hepatocellular carcinoma: Insight from animal models. Nat Rev Gastroenterol Hepatol 2012;9:32-43.
3. McCabe ER: Dax1: Increasing complexity in the roles of this novel nuclear receptor. Mol Cell Endocrinol 2007;265-266:179-182.
4. El-Khairi R, Martinez-Aguayo A, Ferraz-de-Souza B, Lin L, Achermann JC: Role of dax-1 (nr0b1) and steroidogenic factor-1 (nr5a1) in human adrenal function. Endocr Dev 2011;20:38-46.
5. Jadhav U, Harris RM, Jameson JL: Hypogonadotropic hypogonadism in subjects with dax1 mutations. Mol Cell Endocrinol 2011;346:65-73.
6. Li N, Liu R, Zhang H, Yang J, Sun S, Zhang M, Liu Y, Lu Y, Wang W, Mu Y, Ning G, Li X: Seven novel dax1 mutations with loss of function identified in chinese patients with congenital adrenal hypoplasia. J Clin Endocrinol Metab 2010;95:E104-111.
7. Lalli E, Alonso J: Targeting dax-1 in embryonic stem cells and cancer. Expert Opin Ther Targets 2010;14:169-177.
8. Lanzino M, Maris P, Sirianni R, Barone I, Casaburi I, Chimento A, Giordano C, Morelli C, Sisci D, Rizza P, Bonofiglio D, Catalano S, Ando S: Dax-1, as an androgen-target gene, inhibits aromatase expression: A novel mechanism blocking estrogen-dependent breast cancer cell proliferation. Cell Death Dis 2013;4:e724.
9. Nakamura Y, Suzuki T, Arai Y, Sasano H: Nuclear receptor dax1 in human prostate cancer: A novel independent biological modulator. Endocr J 2009;56:39-44.
10. Moeini A, Cornella H, Villanueva A: Emerging signaling pathways in hepatocellular carcinoma. Liver cancer 2012;1:83-93.
11. Shiraha H, Yamamoto K, Namba M: Human hepatocyte carcinogenesis (review). Int J Oncol 2013;42:1133-1138.
12. Dahmani R, Just PA, Perret C: The wnt/beta-catenin pathway as a therapeutic target in human hepatocellular carcinoma. Clin Res Hepatol Gastroenterol 2011;35:709-713.
13. Nedumaran B, Hong S, Xie YB, Kim YH, Seo WY, Lee MW, Lee CH, Koo SH, Choi HS: Dax-1 acts as a novel corepressor of orphan nuclear receptor hnf4alpha and negatively regulates gluconeogenic enzyme gene expression. J Biol Chem 2009;284:27511-27523.
14. Nedumaran B, Kim GS, Hong S, Yoon YS, Kim YH, Lee CH, Lee YC, Koo SH, Choi HS: Orphan nuclear receptor dax-1 acts as a novel corepressor of liver x receptor alpha and inhibits hepatic lipogenesis. J Biol Chem 2010;285:9221-9232.
15. Li J, Lu Y, Liu R, Xiong X, Zhang Z, Zhang X, Ning G, Li X: Dax1 suppresses fxr transactivity as a novel corepressor. Biochem Biophys Res Commun 2011;412:660-666.
16. Li M, Yang Y, He ZX, Zhou ZW, Yang T, Guo P, Zhang X, Zhou SF: Microrna-561 promotes acetaminopheninduced hepatotoxicity in hepg2 cells and primary human hepatocytes through downregulation of the nuclear receptor corepressor dosage-sensitive sex-reversal adrenal hypoplasia congenital critical region on the x chromosome, gene 1 (dax-1). Drug Metab Dispos 2014;42:44-61.
17. Anastas JN, Moon RT: Wnt signalling pathways as therapeutic targets in cancer. Nat Rev Cancer 2013;13:11-26.
18. Niehrs C: The complex world of wnt receptor signalling. Nat Rev Mol Cell Biol 2012;13:767-779.
19. Zeki SS, Graham TA, Wright NA: Stem cells and their implications for colorectal cancer. Nat Rev Gastroenterol Hepatol 2011;8:90-100.
20. Crawford PA, Dorn C, Sadovsky Y, Milbrandt J: Nuclear receptor dax-1 recruits nuclear receptor corepressor n-cor to steroidogenic factor 1. Mol Cell Biol 1998;18:2949-2956.
21. Ehrlund A, Anthonisen EH, Gustafsson N, Venteclef N, Robertson Remen K, Damdimopoulos AE, Galeeva A, Pelto-Huikko M, Lalli E, Steffensen KR, Gustafsson JA, Treuter E: E3 ubiquitin ligase rnf31 cooperates with dax-1 in transcriptional repression of steroidogenesis. Mol Cell Biol 2009;29:2230-2242.